<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04775914</url>
  </required_header>
  <id_info>
    <org_study_id>H-18051256b</org_study_id>
    <nct_id>NCT04775914</nct_id>
  </id_info>
  <brief_title>Intravascular Ultrasound Guided PCI in STEMI</brief_title>
  <acronym>iSTEMI</acronym>
  <official_title>The STEMI Optimization Trial - Intravascular Ultrasound Guided PCI in STEMI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Engstrom</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of is study is to investigate whether intravascular ultrasound-guided (IVUS)&#xD;
      percutaneous coronary intervention (PCI) improve the clinical outcome of patients with&#xD;
      ST-segment elevation myocardial infarction treated with primary PCI.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2031</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>2x2 factorial&#xD;
As a second randomization to the iPOST2 trial (ID: H-180512561,NCT03787745) patients are randomized 1:1 to either a) receiving ultrasound guidance before and after stent placement or b) no ultrasound, independently of randomization in the iPOST2 trial. The iPOST2 trial was initiated February 2019.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>iPOST</measure>
    <time_frame>Until expected number of events are adjudicated up til 3 years</time_frame>
    <description>Number of participants that experience all-cause mortality or hospitalization for heart failure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IVUS</measure>
    <time_frame>Until expected number of events are adjudicated up til 3 years</time_frame>
    <description>Number of participants that experience all-cause mortality, target vessel revascularization and new myocardial infarction</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">2500</enrollment>
  <condition>ST Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>PCI standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>PCI standard + ischemic conditioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stent with ultrasound</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stent without ultrasound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI + Ischemic conditioning</intervention_name>
    <description>IPOST is repeated for 4 cycles (60 sec obstruction followed by 60 sec perfusion each) and followed by stent implantation with a 1.1/1.0 ratio of stent diameter/reference vessel diameter and a stent length sufficient to cover the entire lesion from healthy to healthy area of the vessel. During the first cycle of re-occlusion of full vessel occlusion is secured by a small injection of contrast.</description>
    <arm_group_label>PCI standard</arm_group_label>
    <arm_group_label>PCI standard + ischemic conditioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stent with ultrasound</intervention_name>
    <description>IVUS catheters are to be advanced at least 20 mm distal to the culprit lesion. After administration of intracoronary nitroglycerine, an IVUS-pullback is to be performed at 0.5mm/second using a commercially available imaging system. Stent size and landing zones are decided based on the IVUS.</description>
    <arm_group_label>Stent with ultrasound</arm_group_label>
    <arm_group_label>Stent without ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥18 years&#xD;
&#xD;
          -  Acute onset of chest pain with &lt;12 hours duration&#xD;
&#xD;
          -  STEMI as characterized by 2 mm ST elevation in 2 or more V1 through V4 leads or&#xD;
             presumed new left bundle branch block with minimum of 1 mm concordant ST elevation or&#xD;
             1 mV ST-segment elevation in the limb lead (II, III and aVF, I, aVL) and V4-V6 or ST&#xD;
             depression in 2 or more V1 through V4 leads indicating posterior AMI.&#xD;
&#xD;
        Exclusion Criteria (iPOST2):&#xD;
&#xD;
        Pre-PCI TIMI flow 0 or 1 Potential pregnancy Inability to provide informed consent&#xD;
        Unwillingness to consent Unavoidable to use thrombectomy Spontaneous coronary artery&#xD;
        dissection Time from symptoms onset to PPCI &gt; 12 hours Culprit in bypass graft Other reason&#xD;
        for not including the patient&#xD;
&#xD;
        Exclusion Criteria (iSTEMI):&#xD;
&#xD;
        Potential pregnancy Inability to understand information in order to provide informed&#xD;
        consent Unwillingness to consent Spontaneous coronary artery dissection Time from symptoms&#xD;
        inset to PPCI &gt; 12 hours Culprit in bypass graft Other reason&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas Engstrøm, MD PhD DMSci</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacob Lønborg, MD PhD DMSci</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francis Joshi, Md, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thomas Engstrøm, MD PhD DSci</last_name>
    <phone>+45 3545 8444</phone>
    <email>Thomas.Engstroem@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jacob Lønborg, MD PhD DMSci</last_name>
    <phone>+45 3545 8176</phone>
    <email>jacob.thomsen.loenborg01@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Center, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <state>Capital Region</state>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <contact>
      <last_name>Thomas Engstrom, MD PhD DSci</last_name>
      <phone>+4535458444</phone>
      <email>thomas.engstroem@rh.regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Jacob Lønborg</last_name>
      <phone>+4535458176</phone>
      <email>jacob.thomsen.loenborg01@regionh.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Thomas Engstrom, MD PhD DSci</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacob T Lønborg, MD PhD DMSci</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francis Joshi, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 17, 2021</study_first_submitted>
  <study_first_submitted_qc>February 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2021</study_first_posted>
  <last_update_submitted>March 29, 2021</last_update_submitted>
  <last_update_submitted_qc>March 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Thomas Engstrom</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Primary PCI</keyword>
  <keyword>Coronary angiography</keyword>
  <keyword>Intravascular ultra sound (IVUS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

